CU6 - General discussion, page-359

I'm with you on that ma.

Opportunity cosr is always a big consideration for me. That's why I like to move around a bit to get the quickest, easiest moves on stocks; all the while building my long-term position in my favourites.

Hard to say which og these two have the most potential in the short term but TLX has two products for approval around mid year worth a billion plus annually and UK and Europe approval dropping any time now. So there should be a few extra dollars on the SP in the next few months.

Healthy trial data here will make this pop too so im holding both.